Table 1. Characteristics of all patients and comparison of groups divided according type of gastric reconstruction.
| All patients (n:238) | Billroth-I gastroduodenostomy (n: 147) | Billroth-II gastrojejunostomy (n: 91) | p value | ||
|---|---|---|---|---|---|
| Age (year) | 62.9 ± 8 | 62.9 ± 8.1 | 63.03 ± 7.9 | 0.920 | |
| Sex | 0.086 | ||||
| Male | 179 (75%) | 105 (71%) | 74 (81%) | ||
| Female | 59 (25%) | 42 (29%) | 17 (19%) | ||
| Duration of diabetes (years) | 8 (0–36) | 9 (0–36) | 7.5 (0–24) | 0.075 | |
| Weight (kg) | 65.9 ± 8 | 64.9 ± 8.3 | 67.5 ± 7.3 | 0.016 | |
| Body mass index (kg/m2) | 24.3 ± 2.3 | 24.1 ± 2.3 | 24.6 ± 2.2 | 0.085 | |
| Body mass index classa | 0.210 | ||||
| Normal weight | 142 (59%) | 93 (63%) | 49 (54%) | ||
| Overweight | 96 (41%) | 54 (37%) | 42 (46%) | ||
| Fasting blood glucose (mg/dL) | 137 (61–285) | 139 (61–261) | 131 (67–285) | 0.415 | |
| HbA1c (%) | 7.2 (4.5–14.8) | 7.1 (4.5–14.8) | 7.4 (5.7–10.7) | 0.607 | |
| Antidiabetic treatment | 0.805 | ||||
| No treatment | 42 (17%) | 27 (18%) | 15 (17%) | ||
| Oral medication | 171 (73%) | 107 (73%) | 64 (70%) | ||
| Insulin | 12 (5%) | 7 (5%) | 5 (5%) | ||
| Both | 13 (5%) | 6 (4%) | 7 (8%) | ||
| Histologyb | 0.059 | ||||
| Differentiated | 159 (67%) | 105 (71%) | 54 (59%) | ||
| Undifferentiated | 79 (33%) | 42 (29%) | 37 (41%) | ||
| T classificationc | 0.687 | ||||
| T1 | 212 (89%) | 130 (88%) | 82 (90%) | ||
| T2 | 26 (11%) | 17 (12%) | 9 (10%) | ||
| N classificationc | 0.488 | ||||
| N0 | 223 (94%) | 139 (95%) | 84 (92%) | ||
| N1 | 15 (6%) | 8 (5%) | 7 (8%) | ||
| Pathological stagec | 0.928 | ||||
| Stage Ia | 197 (83%) | 122 (83%) | 75 (82%) | ||
| Stage Ib | 41 (17%) | 25 (17%) | 16 (18%) | ||
abased on World Health Organization classification
bdifferentiated type includes papillary adenocarcinoma and well or moderately differentiated tubular adenocarcinoma, and undifferentiated type includes poorly differentiated adenocarcinoma, signet-ring cell carcinoma, undifferentiated carcinoma, or mucinous adenocarcinoma.
cbased on American Joint Committee on Cancer guidelines-7th edition.